These therapies for kidney cancer are still in clinical testing, but their successful use in other types of cancers suggests that they may ultimately prove beneficial
for kidney cancer patients as well.
Lead author Christina von Roemeling, a graduate student at Mayo Clinic in Florida, used genomic profiling of nearly 100
kidney cancer patient samples to identify genes that were either over-expressed or under - expressed as compared to patient matched normal kidney tissue samples.
Currently, immunotherapy is approved by the Food and Drug Administration (FDA) to
treat kidney cancer patients only after they've tried more traditional therapies, such as targeted therapies killing the cancer's blood supply.
Half of female
kidney cancer patients with substantial abdominal fat at the time of diagnosis died within 3 1/2 years, while more than half of women with little belly fat were still alive 10 years later, the researchers found.
Swanton and his team took biopsies from four
kidney cancer patients at various locations within the same tumors, and from metastases, at different times during their course of treatments.
A cross-sectional CT scan of a female
kidney cancer patient shows relatively little visceral fat (red) and more subcutaneous fat (blue).
Should the results of this study be repeated in the larger Phase III trial, it would lead to a new standard of care
for kidney cancer patients, said Dr. Hammers, formerly of Johns Hopkins medical system, who holds the Eugene P. Frenkel, M.D. Scholar in Clinical Medicine at UT Southwestern.
The second clinical study COG - ANGIO (Pr Joly) demonstrated that antiangiogenics exert a direct negative impact on cognitive functions and fatigue
in kidney cancer patients.
That's why it's particularly important for
kidney cancer patients to get their immunotherapy from a cancer center like ours.
Kidney cancer patients may see long - lasting tumor shrinkage with immunotherapy, which uses the immune system as a weapon to fight cancer.
This page features information on kidney cancer and immunotherapy clinical trials for
kidney cancer patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to kidney cancer patients.
Kidney Cancer UK offers patient support services which are available for
kidney cancer patients and their families.